More Drugs, Better Survival in Metastatic Colon Cancer

(MedPage Today) -- Addition of oxaliplatin to FOLFIRI and bevacizumab doubled 5-year survival.

Source: MedPage Today Primary Care - January 13, 2015 Category: Primary Care Source Type: news